Pilot Study to Assess the Efficacy and Safety of Boceprevir, in Combination With Peg-Interferon Alfa and Ribavirin, in Patients With HCV/HIV Co-infection Who Have Failed to a Previous Therapy With Peg-Interferon/Ribavirin
Phase of Trial: Phase II
Latest Information Update: 05 May 2016
At a glance
- Drugs Boceprevir (Primary) ; Peginterferon alfa-2b; Ribavirin
- Indications Hepatitis C
- Focus Therapeutic Use
- Acronyms BocepreVIH
- 10 Jun 2017 Biomarkers information updated
- 05 May 2016 Results of a pharmacogenetic substudy (n=232) from ANRS HC26 and HC27 studies published in the AIDS.
- 01 Mar 2016 Results published in the HIV Clinical Trials.